Market Access News | pharmaphorum

News

NICE axes funding for MSD's Keytruda in bladder cancer despi...

NICE has axed funding for MSD’s Keytruda for second-line advanced bladder cancer in final guidance, despite an appeal from the company.

News

NICE backs AZ’s Calquence for new use in leukaemia

AstraZeneca’s BTK inhibitor Calquence has become the first targeted oral therapy to be backed by NICE for NHS England patients with chronic lymphocytic leukaemia (CLL) who can’t be treated

News

Ireland, Netherlands suspend AstraZeneca COVID-19 vaccinatio...

Ireland and the Netherlands have joined Norway, Denmark, Bulgaria and Iceland in suspending vaccinations with Oxford/AstraZeneca’s COVID-19 vaccine, shortly after the World Health Organizat

News

Novartis says £1.8m Zolgensma is model for gene therapy pric...

Novartis has said its gene therapy pricing model, involving a steep one-off payment, could be a template for the hundreds of similar treatments that could follow its Zolgensma for Spinal Mu

News

J&J’s COVID-19 shot backed for emergency use in EU

The EU’s medicines regulator has recommended granting conditional approval to a fourth COVID-19 vaccine – a single-dose shot from Johnson & Johnson’s Janssen unit – after a review by it

News

Janssen J&J Johnson and Johnson pharmaceutical companies

J&J manufacturing delays hit US vaccine rollout

The rollout of the US COVID-19 vaccination programme slowed up this week because manufacturing delays mean no new doses of the recently approved Johnson & Johnson vaccine are available.

NICE axes funding for MSD's Keytruda in bladder cancer despi...

NICE backs AZ’s Calquence for new use in leukaemia

Ireland, Netherlands suspend AstraZeneca COVID-19 vaccinatio...

Novartis says £1.8m Zolgensma is model for gene therapy pric...

J&J’s COVID-19 shot backed for emergency use in EU

J&J manufacturing delays hit US vaccine rollout

Immunovant's thyroid eye disease drug flunks pivotal trials

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks